ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Imjudo 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung - 
68706002 AstraZeneca AG
Imjudo 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung13.09.2023
  13.09.2023
(L01FX20) 
WHO-DDD12.09.2028
07.16.10. 
07.16.10. 
A  
Yes 
IP 
17144.04Yes
    
10 %17897.60
  
7680687060028Biotechnologika
  
Composition
tremelimumabum 300 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, dinatrii edetas corresp. natrium 0.185 mg, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 15 ml.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Tremelimumabum300mg / 15ml
BAG: Active AgentDose
Tremelimumabum300 mg
 
Inactive agents
Dinatrii Edetas
Histidin Hydrochloride Monohydrate
Histidine
Polysorbatum 80
Trehalosum Dihydricum
 
Source
Data was imported : 07.10.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home